Related Experiment Video
Updated: Apr 27, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
Design of Clofazimine-Loaded Lipid Nanoparticles Using Smart Pharmaceutical Technology Approaches.
Helena Rouco1,2,3, Nicola Filippo Virzì4, Carolina Menéndez-Rodríguez5
1Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, Grupo I+D Farma (GI-1645), Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
This study developed improved clofazimine (CFZ) antimicrobial formulations using nanostructured lipid carriers (NLCs). Smart pharmaceutical technologies enhanced drug delivery, showing promising biocompatibility and efficacy against Staphylococcus aureus.
Area of Science:
- Pharmaceutical Technology
- Nanomedicine
- Antimicrobial Drug Delivery
Background:
- Clofazimine (CFZ) exhibits broad-spectrum antimicrobial activity but faces limitations due to poor solubility and side effects.
- Nanostructured lipid carriers (NLCs) offer a promising strategy to enhance drug bioavailability and safety.
- Developing effective nanoparticle formulations presents significant challenges.
Purpose of the Study:
- To develop optimized Clofazimine-loaded Nanostructured Lipid Carriers (CFZ-NLCs) using smart pharmaceutical technologies.
- To leverage Artificial Intelligence (AI) and Neurofuzzy Logic (NFL) for formulation design and understanding.
- To evaluate the biocompatibility and antimicrobial efficacy of the developed CFZ-NLCs.
Main Methods:
- Application of an AI-established design space for CFZ-NLC formulation development.
- Utilizing Neurofuzzy Logic (NFL) and in silico docking to analyze NLC component interactions.
- Characterization of formulation biocompatibility with murine fibroblasts and antimicrobial activity against *Staphylococcus aureus*.
Main Results:
- Successful development of CFZ-NLCs with optimal characteristics, including small particle size and high drug loading.
- NFL provided insights into NLC component interactions and homogenization effects on formulation properties.
- In silico docking confirmed drug-lipid matrix interactions, and formulations showed good biocompatibility and antimicrobial activity.
Conclusions:
- Smart pharmaceutical strategies, including AI and NFL, facilitate efficient design of advanced antimicrobial delivery systems.
- The developed CFZ-NLCs demonstrate potential for improved antimicrobial therapeutics.
- This approach enables more efficient development of novel nanoparticle-based drug delivery systems.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

